Innovator’s Pitch Challenge
Interested in Connecting? Please contact:
Auriane Gamelin
COO
agamelin@oncoxome.com
Message the company or request a 1:1 meeting here.
OncoXome is an oncology startup whose objective is to bring to patients with advanced cancer an innovative multitarget therapeutic approach hacking cell communication and using gene editing to overcome cancer resistance.
We have two platforms: a proprietary exosome scalable production and gene editing therapy. Combined, these platforms lead to a targeted therapeutic delivery.
We first target patients with advanced KRAS mutated lung, colorectal and pancreatic cancers.